Researchers recruited 60 adults aged 18 to 74 to test how the brain supports paired-associate memory. Participants viewed pictures of objects and scenes paired with faces, rested for five minutes, then completed a recognition test in which they selected the object or scene originally associated with each face. During the recall phase, participants underwent MRI scanning to observe hippocampal activity and pattern reactivation.
The study focused on the hippocampus because this structure binds disparate pieces of information and underlies many forms of associative memory. As co-lead author Ian McDonough, PhD, explained, the ability to remember pairs of items — analogous to remembering a name with a face — depends on the intactness and function of the hippocampus.
Comparing age groups, investigators found a marked decline in memory accuracy between younger adults (20–30) and middle-aged participants (50–63). This pattern suggests that the transition in memory performance may occur in middle age, earlier than is commonly assumed.
When examining the neural mechanisms behind errors, the researchers observed distinct age-related differences. In young adults, incorrect responses tended to reflect a failure to reactivate the original memory pattern. By contrast, older adults (63–74) often showed increased reactivation of hippocampal patterns even when their answers were wrong. In other words, the same pattern of hippocampal reactivation that typically indicates a vivid, accurate recall in youth was paradoxically associated with poorer accuracy in older adults.
McDonough characterized this as an unexpected finding: aging appears to change not just the magnitude of hippocampal activity but the functional meaning of that activity. Older adults’ hippocampal activity can remain high while producing less accurate memories.
Clinicians not involved in the study highlighted that these results align with observations that the neurological processes leading to manifest memory impairment often begin long before symptoms prompt clinical visits. Manisha Parulekar, MD, noted the study demonstrated a significant drop in memory accuracy by people’s 50s and emphasized that the aging brain does not simply “power down.” Instead, it remains active but begins to misbind details, producing confident but incorrect pairings (for example, pairing a familiar face with an incorrect category of image).
The investigators further reported that these specific error patterns were not explained solely by brain shrinkage. Rather, they reflect a shift in how the hippocampus and memory circuits communicate internally as people age.
Outside neurologists framed the study as an initial move toward developing a combined structural and functional imaging biomarker for memory decline. Andrew Tarulli, MD, described the fMRI-based approach as potentially complementary to current clinical assessments but cautioned it is not yet ready for clinical application. He recommended further longitudinal work, including retesting participants to track changes in hippocampal functional connectivity and expanding fMRI investigations to other cortical regions involved in memory processing.
Such work could help identify early-stage functional shifts that precede clinical decline and might, in time, inform earlier interventions or trials of therapies intended to slow progression.
Physicians quoted in the article reiterated that there is no guaranteed prevention for memory loss or dementia. Nonetheless, several lifestyle and medical strategies support brain health across adulthood and may reduce risk factors associated with cognitive decline. Recommended measures include:
Clinicians emphasized that what benefits cardiovascular health generally benefits the brain and encouraged patients to work with their healthcare providers to “know their numbers” and address modifiable risks.
Physicians urged attention to persistent change over time rather than isolated instances of forgetfulness. Signs warranting clinical evaluation include repeated difficulty managing medications or finances, getting lost in familiar places, or a clear decline from a person’s previous level of functioning.
Evaluation may include cognitive testing, medication review, assessment of sleep and mood, laboratory tests for reversible causes, and referral for specialized assessment when appropriate. The article’s clinical voices stressed early recognition and monitoring so that potentially reversible contributors can be addressed and so that patients can be considered for interventions or further testing as research advances.
(Details such as exact statistical results, effect sizes, or additional methodology beyond what was reported in the source article were not provided in the source.)